1. Introduction

Compulsory Genome Accountability Doctrine and Governance is a proposed legal and regulatory framework for examining when the state, courts, employers, healthcare institutions, research organisations, or biotechnology companies may require individuals to provide genetic material or undergo genomic testing, and how those exercising such powers should be held accountable.

The subject lies at the intersection of constitutional law, biotechnology law, medical ethics, data protection, human rights, administrative law, criminal justice, and biosecurity.

A genome contains information encoded in an individual's DNA. Depending on the type of analysis, genomic information may reveal identity, biological relationships, inherited disease risks, ancestry, and information relevant to biological relatives. Genetic information can also be reinterpreted as scientific methods advance.

Compulsory genome-related measures may include:

• Mandatory DNA sampling for criminal investigations.
• Court-ordered genetic testing in disputed parentage cases.
• Compulsory genetic screening for specified public-health purposes.
• Mandatory genomic testing in regulated clinical or research settings.
• Collection and retention of DNA profiles in government databases.
• Required disclosure of genetic information for legally defined administrative purposes.
• Genomic surveillance of particular populations.
• Genetic testing imposed as a condition of employment, insurance, education, or access to public services.

These measures raise a fundamental question:

Can an institution compel a person to surrender genetic information in the public interest, and what legal safeguards must govern that power?

The answer depends on the jurisdiction, the statutory authority, the purpose of testing, the information collected, and the consequences for the individual.

There is no single universally recognised legal doctrine formally called the Compulsory Genome Accountability Doctrine. The term is best understood as a proposed analytical framework built from established principles of privacy, bodily autonomy, proportionality, equality, procedural fairness, scientific reliability, and institutional accountability.

In India, the constitutional starting point is the right to privacy recognised in K.S. Puttaswamy v. Union of India (2017). International human-rights jurisprudence, particularly S. and Marper v. United Kingdom (2008), also provides important guidance on the collection and retention of genetic material. Indian Kanoon

2. Meaning of the Doctrine

The proposed doctrine can be divided into three connected elements.

A. Compulsory genome regulation

This concerns the legal authority to require a person to submit a biological sample or undergo genetic testing without relying entirely on voluntary consent.

Examples include:

• DNA testing ordered by a court.
• Statutorily authorised DNA collection in criminal investigations.
• Genetic testing required under a narrowly defined public-health law.

The existence of a legitimate public purpose does not automatically make compulsory testing lawful. The authority must also comply with applicable constitutional and statutory requirements.

B. Genome accountability

Genome accountability concerns the responsibility of institutions that collect, analyse, store, disclose, transfer, or use genetic information.

Accountability may involve:

1. Identifying the legal authority for collection.
2. Recording the purpose of the test.
3. Ensuring the laboratory uses scientifically valid methods.
4. Restricting access to authorised personnel.
5. Preventing unauthorised secondary uses.
6. Providing procedures for correcting errors and challenging decisions.
7. Establishing liability and remedies for unlawful collection, disclosure, or misuse.
8. Ensuring that retained samples and records are securely destroyed when legally appropriate.

Accountability extends beyond the individual who provides a sample. It may also involve laboratories, public authorities, private genomic-testing companies, database operators, contractors, and researchers.

C. Genome governance

Genome governance concerns the institutional arrangements through which genetic information is regulated.

These arrangements may include:

• Legislation and regulations.
• Independent regulatory oversight.
• Data-protection and cybersecurity standards.
• Ethical review of research.
• Laboratory accreditation and quality assurance.
• Judicial review and independent appeals.
• Public reporting and institutional audits.
• Rules governing international transfers of genetic information.

The central distinction is that compulsory testing concerns the power to obtain genetic information, accountability concerns responsibility for exercising that power, and governance concerns the system that controls it.

A legitimate system must address all three.

3. Constitutional foundations of compulsory genome governance in India

3.1 Article 21: Right to life, privacy, and personal liberty

Article 21 of the Constitution of India protects life and personal liberty. The Supreme Court has interpreted it to protect privacy, dignity, and important aspects of individual autonomy.

Genomic testing implicates Article 21 because it may involve:

• Taking blood, saliva, hair, or other biological material.
• Accessing information about inherited conditions.
• Discovering biological relationships.
• Retaining genetic samples after the original purpose has ended.
• Sharing genetic data with law-enforcement agencies or third parties.

A compulsory genomic-testing requirement must therefore be assessed in light of the applicable law and the constitutional rights of the affected person.

In K.S. Puttaswamy v. Union of India (2017), the Supreme Court recognised privacy as a fundamental right. Its reasoning provides the foundation for challenging unjustified compulsory genomic collection and processing.

The constitutional analysis generally requires consideration of three questions:

1. Legality: Is there a valid legal basis for the interference?
2. Legitimate aim: Does the measure pursue a constitutionally permissible public purpose?
3. Proportionality: Is the interference appropriately limited and justified in relation to that purpose?

The proportionality assessment also requires attention to safeguards against arbitrary use, excessive collection, and unauthorised disclosure. Indian Kanoon

Legal consequence: A government department ordinarily cannot create a compulsory genome-testing programme merely through an administrative circular if the programme requires a legal authority that the circular does not supply.

3.2 Article 14: Equality and non-arbitrariness

Article 14 guarantees equality before the law and equal protection of the laws.

A compulsory genomic programme may violate Article 14 if it:

• Targets particular communities without a rational and lawful basis.
• Treats genetic susceptibility as proof of future misconduct.
• Imposes discriminatory burdens on disadvantaged groups.
• Uses unreliable genomic predictions to determine eligibility for benefits.
• Applies testing requirements inconsistently to similarly situated individuals.

For example, suppose a public authority requires genetic testing only for members of a particular ethnic community to determine eligibility for a government benefit. The policy would raise serious equality and privacy concerns, particularly if the classification lacks a legitimate, evidence-based justification.

The relevant constitutional inquiry would examine the classification, its objective, the evidence supporting it, and whether the measure is arbitrary or disproportionate.

3.3 Article 20(3): Protection against compelled self-incrimination

Article 20(3) protects an accused person from being compelled to be a witness against themselves.

Genetic evidence presents a complicated question because providing a physical sample is not necessarily equivalent to giving testimonial evidence.

In State of Bombay v. Kathi Kalu Oghad (1961), the Supreme Court distinguished testimonial compulsion from the provision of physical identifying material.

The judgment is relevant to compulsory DNA collection, but it does not establish that every form of genetic testing is constitutionally permissible. The purpose of the sample, the applicable law, the nature of the procedure, and the privacy interests involved must also be considered.

Important distinction: A DNA profile used to identify a suspect is legally different from genomic analysis intended to reveal disease susceptibility, psychological characteristics, or inherited traits. The latter may raise additional privacy and autonomy concerns.

3.4 Article 19: Freedom and occupational consequences

Article 19 may become relevant when genomic information is used to restrict lawful activities, professional opportunities, or expression, depending on the right and the circumstances involved.

For instance, a compulsory genetic-testing policy that excludes people from particular professions based on a predicted future illness could raise questions under Articles 14 and 21 and, where applicable, Article 19.

A restriction must be assessed against the constitutional protection it affects; an institution cannot justify a discriminatory decision merely by describing it as scientific risk management.

4. Leading case laws on compulsory genomic testing and accountability

The following cases provide the principal judicial foundations for the proposed doctrine. Some concern DNA testing directly; others establish broader constitutional or human-rights principles applicable to genomic governance.

Case 1: K.S. Puttaswamy v. Union of India (2017)

Citation: (2017) 10 SCC 1
Court: Supreme Court of India
Subject: Fundamental right to privacy

Facts and legal issue

The Supreme Court considered whether privacy is protected as a fundamental right under the Constitution of India.

The case arose in the context of challenges concerning the constitutional status of privacy and its relationship with state action and personal autonomy.

Judgment

The Court recognised privacy as a fundamental right, rooted in the constitutional guarantees of liberty, dignity, and other protected freedoms.

The judgment also established that privacy is not absolute. State interference must satisfy applicable constitutional requirements, including legality, a legitimate state purpose, and proportionality.

Application to compulsory genome governance

The judgment supports several principles:

First, genetic information is entitled to meaningful privacy protection. Genomic data can reveal information extending beyond an individual's immediate identity.

Second, compulsory collection requires justification. A public authority must identify a legitimate legal basis and cannot rely solely on administrative convenience.

Third, the original purpose matters. A sample collected to identify a criminal suspect should not automatically become available for unrelated health profiling or research.

Fourth, safeguards are essential. Access controls, limits on retention, and protection against unauthorised disclosure are important elements of a constitutionally defensible system.

Legal significance

Puttaswamy is the constitutional starting point for evaluating compulsory genome collection and processing in India. It supports the proposition that genetic privacy is not simply a matter of institutional policy; it engages constitutional rights.

Official judgment: Supreme Court of India judgment in Puttaswamy.

Case 2: R. Rajendran v. Kamar Nisha (2025)

Citation: 2025 INSC 1304; Criminal Appeal No. 1013 of 2021
Court: Supreme Court of India
Decision date: 10 November 2025
Subject: Compulsory DNA testing, parentage, privacy, and legitimacy

Facts

The case arose from a dispute in which a woman sought DNA profiling in connection with the paternity of a child. The litigation raised the question of whether a person could be compelled to provide a sample when the asserted parentage dispute had to be considered alongside the legal presumption concerning children born during a valid marriage.

Judgment and principles

The Supreme Court examined the circumstances in which DNA testing may be ordered and the relationship between scientific evidence, privacy, and the presumption of legitimacy.

The judgment reinforces the principle that DNA testing should not be ordered automatically whenever a party requests it. Courts must examine whether the test is legally justified and necessary to resolve the dispute.

The Court also emphasised the importance of the presumption of legitimacy under Section 112 of the Indian Evidence Act, 1872, as applicable to the dispute, and the need for strong, cogent evidence to rebut that presumption.

The judgment treats compelled DNA testing as a serious intrusion into privacy and personal liberty, requiring consideration of legality, legitimate purpose, and proportionality. API Sci

Application to genome accountability

This case is particularly important because it illustrates that scientific accuracy does not automatically determine legal permissibility.

A DNA test may be capable of answering a biological question, but the court must also consider:

• Whether the evidence is legally relevant.
• Whether testing is necessary to decide the dispute.
• Whether the privacy interests of the person being tested are protected.
• Whether the child's dignity and welfare are affected.
• Whether less intrusive evidence can resolve the issue.

Legal significance

R. Rajendran is a particularly relevant recent authority for the proposition that the availability of genetic testing does not create an unrestricted legal power to compel it.

Official judgment: Supreme Court of India, R. Rajendran v. Kamar Nisha.

Case 3: Bhabani Prasad Jena v. Orissa State Commission for Women (2010)

Citation: (2010) 8 SCC 633
Court: Supreme Court of India
Subject: Court-ordered DNA testing and privacy

Facts

The case concerned the use of DNA testing in a dispute involving alleged paternity and the propriety of judicially directing such testing.

Legal issue

The central issue was whether the availability of modern scientific techniques justified directing DNA testing whenever parentage was disputed.

Judgment

The Supreme Court cautioned that DNA testing is a sensitive matter and that courts must exercise restraint when directing it.

The Court recognised that scientific evidence may help establish biological relationships but can also invade privacy and cause serious consequences for the parties, particularly children.

The decision supports a case-specific assessment rather than an automatic order for testing.

Application to genome accountability

This judgment establishes an important distinction between scientific capability and legal necessity.

A court considering a DNA test should ask:

1. Is the proposed test genuinely necessary?
2. Is the disputed fact material to the proceedings?
3. Can the issue be decided through other evidence?
4. What privacy and dignity interests will be affected?
5. What consequences might disclosure of the result have for a child or family?

Legal significance

Bhabani Prasad Jena is relevant to the proposed doctrine because it places limits on judicial discretion and requires a reasoned justification for intrusive genetic testing.

Case 4: Selvi v. State of Karnataka (2010)

Citation: (2010) 7 SCC 263
Court: Supreme Court of India
Subject: Compelled scientific techniques, personal liberty, and self-incrimination

Facts

The case concerned the compulsory administration of investigative techniques such as narcoanalysis, polygraph examinations, and brain electrical activation profile tests.

Judgment

The Supreme Court held that the involuntary administration of the techniques at issue violated constitutional protections, including Article 20(3) and Article 21, in the circumstances considered by the Court.

The judgment addressed the distinction between voluntary participation and compelled procedures that intrude upon mental privacy and personal autonomy.

Application to compulsory genome governance

Selvi did not decide the general constitutionality of compulsory DNA profiling. It must not be treated as a blanket prohibition on all involuntary biological testing.

Nevertheless, its reasoning is relevant when genomic procedures are combined with intrusive neurological, cognitive, or behavioural assessments.

It supports careful examination of:

• Whether participation is genuinely voluntary.
• Whether a procedure invades protected mental or bodily interests.
• Whether the procedure is authorised by law.
• Whether the evidence is being obtained through constitutionally impermissible compulsion.

Legal significance

Selvi helps distinguish ordinary physical identification from more intrusive scientific procedures. Its principles become especially relevant when compulsory genomic programmes are used to infer cognitive traits, behaviour, or psychological predispositions.

Case 5: S. and Marper v. United Kingdom (2008)

Citation: Applications Nos. 30562/04 and 30566/04
Court: European Court of Human Rights
Decision date: 4 December 2008
Subject: Retention of DNA profiles and biological samples

Facts

Two individuals challenged the retention of their fingerprints, DNA profiles, and biological samples by police authorities.

One applicant had been arrested as a minor but was not convicted. The other had faced criminal proceedings that did not result in a conviction. Nevertheless, their biometric and genetic information remained in police databases.

Legal issue

The central question was whether retaining genetic information from individuals who had not been convicted violated their right to respect for private life under Article 8 of the European Convention on Human Rights.

Judgment

The European Court of Human Rights held that the blanket and indiscriminate retention of the applicants' fingerprints, cellular samples, and DNA profiles violated Article 8.

The Court emphasised that cellular samples contain extensive genetic and health information and that DNA profiles can reveal biological relationships and potentially support inferences about characteristics such as ethnic origin.

The absence of a conviction did not eliminate the applicants' privacy interests. The indiscriminate retention policy failed to strike a fair balance between the public interest in crime prevention and the individuals' rights. HUDOC

Application to compulsory genome governance

This case supports four important principles.

1. Collection and retention are separate legal questions.

Even where obtaining a DNA sample is lawful, keeping it indefinitely may require a separate justification.

2. A person's legal status matters.

The justification for retaining a convicted person's DNA profile may differ from the justification for retaining the genetic information of an acquitted suspect.

3. Genetic information requires heightened safeguards.

Biological samples may contain substantially more information than the limited DNA profile initially generated from them.

4. Indefinite retention requires particularly careful scrutiny.

A database cannot be justified simply by asserting that genetic information might prove useful in some future investigation.

Legal significance

S. and Marper is a leading international authority on genetic-data retention and provides a strong foundation for arguing that compulsory genome governance must include purpose limitation, retention limits, independent review, and deletion procedures.

The judgment is not directly binding on Indian courts, but it offers persuasive comparative guidance.

Official case information: European Court of Human Rights — S. and Marper v. United Kingdom.

Case 6: Maryland v. King (2013)

Citation: 569 U.S. 435 (2013)
Court: Supreme Court of the United States
Subject: DNA collection from individuals arrested for serious offences

Facts

Maryland law authorised the collection of DNA samples from certain individuals arrested for serious offences.

The constitutional challenge concerned whether collecting and analysing DNA during the booking process constituted an unreasonable search under the Fourth Amendment to the US Constitution.

Judgment

The US Supreme Court upheld the particular DNA-collection procedure at issue.

The majority treated the DNA analysis as an identification measure associated with the booking process and relied on the statutory safeguards governing the permitted use of DNA records.

The judgment was context-specific. It did not establish that every form of compulsory genetic testing is constitutionally permissible.

Application to genome accountability

The case illustrates how the legality of compulsory testing may depend on the nature and scope of the analysis.

A limited forensic profile used for identification raises different issues from whole-genome sequencing intended to reveal:

• Hereditary diseases.
• Cognitive or behavioural predispositions.
• Familial relationships unrelated to the investigation.
• Information about biological relatives.

A defensible governance framework should therefore specify what may be analysed, who may access the result, which databases may receive it, and whether further analysis is prohibited.

Legal significance

Maryland v. King demonstrates that a court may uphold a narrowly regulated DNA-identification programme without endorsing unrestricted access to an individual's genome.

The case is persuasive comparative authority, not binding law in India.

Judgment: Cornell Legal Information Institute — Maryland v. King.

5. Statutory framework governing genome accountability in India

The proposed doctrine must operate through existing constitutional and statutory rules. It does not independently create a power to compel genomic testing.

5.1 Constitution of India

The principal constitutional provisions include:

The precise remedy depends on the nature of the violation and the parties involved.

For example, a person challenging a government agency's unlawful retention of genetic material may seek judicial review, while a dispute over a private company's handling of genetic information may require a different statutory or civil remedy.

5.2 Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023, provides a statutory framework for the processing of digital personal data in India.

Its relevance to genomic governance depends on whether the genetic information falls within the Act's scope and on the applicable provisions, rules, exemptions, and commencement arrangements.

Official legislative text: India Code — Digital Personal Data Protection Act, 2023.

For genome accountability, important questions include:

• Was the genetic information collected and processed on a lawful basis?
• Were applicable notice and consent requirements satisfied, or does a lawful exception apply?
• Was the information used only for an authorised purpose?
• Were appropriate security safeguards implemented?
• Was information disclosed to an unauthorised recipient?
• Were applicable rights, duties, and remedies respected?

Important qualification: The Act should not be described as creating an absolute consent requirement for every form of genetic-data processing. Its application must be determined from the operative statutory provisions and applicable exceptions.

Furthermore, genetic data are not automatically outside the Act merely because they are held by a laboratory rather than a consumer-facing digital platform.

5.3 DNA Technology (Use and Application) Regulation Bill, 2018

India's proposed DNA-specific legislation has generated substantial debate about the balance between forensic utility and privacy.

The DNA Technology (Use and Application) Regulation Bill, 2018, proposed a framework for DNA analysis and DNA data banks.

A significant concern raised during legislative scrutiny was whether the proposed system adequately limited the purposes for which DNA profiles could be collected, stored, and used.

Questions included:

• Whether civil disputes should justify storing DNA profiles in forensic databases.
• Whether definitions of DNA profiles sufficiently restricted the information that could be retained.
• Whether individuals would have effective remedies against improper retention or use.
• Whether oversight mechanisms adequately protected privacy.

These concerns are relevant to the proposed accountability doctrine because legislation authorising DNA collection must also regulate what happens after collection.

The 2018 Bill should be treated as a legislative proposal, not as an enacted statute. Its provisions cannot independently authorise compulsory DNA collection.

Background and legislative analysis: PRS Legislative Research — DNA Technology (Use and Application) Regulation Bill, 2018.

6. The seven core principles of compulsory genome accountability

The following seven principles provide a practical analytical framework for evaluating compulsory genomic programmes.

These are proposed components of the doctrine, not a claim that Indian legislation formally recognises a single seven-part legal test.

Principle 1: Legality and authorised purpose

Every compulsory genomic measure should have a clearly identifiable legal basis.

The law should specify:

• Which authority can order or require testing.
• Which individuals may be subject to it.
• The circumstances in which testing is permitted.
• The permissible purposes of analysis.
• The applicable review and appeal mechanisms.

An executive authority should not assume that a general power to collect information automatically includes a power to conduct comprehensive genetic analysis.

Example: A statutory power to collect DNA for criminal identification would not, without further legal authority, necessarily permit the same sample to be used for unrelated research into inherited diseases.

Principle 2: Necessity and proportionality

A genomic measure should be no more intrusive than reasonably necessary to achieve its lawful objective.

The assessment should consider:

1. The seriousness and legitimacy of the objective.
2. The strength of the evidence supporting compulsory testing.
3. The relevance of the proposed genetic analysis.
4. The availability of less intrusive alternatives.
5. The sensitivity of the information collected.
6. The foreseeable effects on the individual and biological relatives.

A requirement for a narrowly targeted DNA profile may be easier to justify than compulsory whole-genome sequencing, because whole-genome sequencing can reveal much more information.

However, the precise legal assessment depends on the governing law and circumstances.

Principle 3: Scientific validity and evidentiary reliability

Genomic information must be generated and interpreted using scientifically appropriate methods.

Accountability requires attention to:

• Laboratory competence and quality control.
• Sample contamination and identification errors.
• Chain of custody.
• Validated analytical methods.
• Statistical interpretation.
• Limitations of genetic predictions.
• Reproducibility and independent verification where necessary.

A genetic association is not automatically proof of causation.

For example, a genetic variant associated with an increased risk of a disease does not necessarily establish that a particular individual will develop that disease.

Similarly, a probabilistic genetic prediction should not automatically be treated as conclusive evidence of a person's future behaviour.

Legal consequence: A decision-maker who treats uncertain genomic predictions as infallible may expose the resulting decision to challenge on grounds such as arbitrariness, procedural unfairness, or evidentiary unreliability.

Principle 4: Data minimisation and purpose limitation

Only the information reasonably necessary for the lawful objective should be collected, analysed, or retained.

A governance system should distinguish between:

• The original biological sample.
• A forensic DNA profile.
• A comprehensive genomic sequence.
• Clinical interpretations.
• Familial information inferred from the data.

These are not interchangeable.

The biological sample may contain information that is not present in a restricted forensic profile. Retaining the original sample may therefore create risks beyond those associated with retaining a limited identification record.

An effective framework should regulate each category separately.

Principle 5: Equality and non-discrimination

Genome governance must prevent genetic information from becoming an instrument of unjustified exclusion.

Potentially problematic practices include:

• Refusing employment because of a predicted genetic disease.
• Excluding people from education based on hereditary characteristics.
• Targeting ethnic or social groups for disproportionate testing.
• Denying public benefits based on unsupported genomic risk predictions.
• Using genetic information to justify discriminatory reproductive policies.

The lawfulness of a particular practice depends on the applicable legislation and constitutional protections.

Nevertheless, genetic differences alone do not establish that a person is unfit for employment, education, parenthood, or participation in society.

Principle 6: Independent oversight and procedural fairness

Compulsory genomic programmes should be subject to meaningful scrutiny.

Depending on the context, safeguards may include:

• Independent review of compulsory testing orders.
• Written reasons for decisions.
• Access to relevant test results.
• Procedures for challenging laboratory errors.
• Review of database retention decisions.
• Confidential complaint mechanisms.
• Judicial remedies for unlawful action.

An institution should not be the sole judge of whether its own intrusive genomic practices are lawful.

Independent scrutiny is particularly important when genetic information is used to make decisions affecting liberty, family relationships, healthcare, employment, or access to public benefits.

Principle 7: Remedies, liability, and institutional accountability

A complete governance system must establish what happens when genomic information is mishandled.

Depending on the facts and applicable law, potential consequences may include:

• Judicial orders restricting further processing.
• Deletion or destruction of information where legally appropriate.
• Correction of inaccurate records.
• Statutory penalties.
• Civil compensation where a recognised cause of action exists.
• Professional disciplinary action.
• Criminal liability where the relevant offence is established.
• Review or reconsideration of a decision based on unlawfully obtained or unreliable information.

Liability should reflect the actual legal duties of the institution and the nature of the wrongdoing. A data breach does not automatically establish every form of liability, and compensation is not automatic in every case.

7. Special issues in compulsory genomic testing

7.1 Criminal investigations

DNA evidence can assist in identifying suspects, linking crime scenes, and exonerating innocent individuals.

However, a legally defensible system must distinguish between obtaining a sample for a specific investigation and retaining that sample for future, potentially unrelated purposes.

Relevant questions include:

• Is collection authorised by law?
• Is the sample relevant to the investigation?
• Are the analytical methods reliable?
• What rules govern retention after acquittal or discharge?
• Can the person seek deletion or review?
• Are familial searches subject to additional safeguards?

The principles in S. and Marper are particularly relevant to retention, while Maryland v. King illustrates the possibility of narrowly authorised DNA identification in criminal proceedings.

7.2 Parentage and family disputes

DNA testing may be important in parentage, inheritance, maintenance, and related disputes.

Nevertheless, the interests of the child, the privacy of the parties, and the legal presumptions governing parentage must be considered.

Bhabani Prasad Jena and R. Rajendran demonstrate why courts should not order DNA tests as a matter of routine.

A scientifically accurate answer to a biological question does not necessarily resolve every legal question arising from parentage.

7.3 Public-health screening

Genetic screening may serve legitimate public-health or clinical purposes, particularly where a test has demonstrated clinical value.

However, compulsory screening requires careful examination of the statutory basis, the importance of the public-health objective, the reliability of the test, and the intrusion into privacy.

A voluntary screening programme with appropriate counselling is legally and ethically different from a programme that threatens penalties or denies essential services to people who refuse testing.

Compulsory measures require specific justification rather than a general assertion that genetic information could be useful.

7.4 Employment and insurance

Genetic information can create a risk of discrimination when employers or insurers use it to predict future disease or other characteristics.

A genome accountability framework should distinguish between clinically relevant information lawfully required for a specific purpose and unjustified collection of an individual's genetic profile.

The relevant legal protections vary by jurisdiction, industry, and type of decision. There is no universal rule that all employment or insurance uses of genetic information are governed identically.

7.5 Research and biotechnology companies

Genomic research may depend on the availability of large datasets, including information derived from biological samples.

Researchers and biotechnology companies must nevertheless consider applicable consent requirements, research approvals, confidentiality duties, data-protection law, contractual restrictions, and other legal obligations.

An institution's possession of a biological sample does not automatically establish unrestricted authority to sequence it, commercialise the results, or transfer the information to third parties.

8. Comparative legal framework: United Kingdom

The United Kingdom provides an example of legislation addressing non-consensual DNA analysis.

Human Tissue Act 2004

Section 45 of the Human Tissue Act 2004 addresses certain forms of non-consensual DNA analysis.

The provision criminalises specified conduct involving bodily material where DNA is intended to be analysed without qualifying consent and the results are to be used for purposes outside the statutory exceptions.

The Act also provides for qualifying consent and exceptions under its relevant schedules.

The legal significance is that the legislation does not treat every use of biological material as unrestricted simply because the material is available to an institution.

Official legislation: UK Human Tissue Act 2004, section 45.

Relevance to India

The UK framework illustrates one possible legislative approach to genetic accountability: regulate not only collection but also the analysis and intended use of human biological material.

However, the UK provision must be interpreted within its own statutory scheme. It is not a direct statement of Indian law.

9. Hypothetical applications of the doctrine

The following examples illustrate how the proposed framework could be applied.

These examples are analytical illustrations, not statements that a specific outcome is inevitable under every jurisdiction's law.

10. Institutional model for genome accountability governance

An effective governance system should distribute responsibilities across several institutions.

A. Legislature

The legislature should define the circumstances in which compulsory genomic testing may occur and establish safeguards against arbitrary collection and use.

B. Courts

Courts should examine the legality and proportionality of compulsory testing orders, protect the rights of affected individuals, and provide appropriate remedies for unlawful action.

C. Laboratories

Laboratories should maintain scientific quality, sample security, accurate records, and appropriate restrictions on disclosure.

D. Data controllers and database operators

Institutions responsible for genetic databases should implement access controls, security safeguards, retention schedules, and procedures for handling unauthorised access.

E. Independent regulators

Regulators should investigate relevant complaints, audit compliance where legally authorised, and impose or recommend consequences within their powers.

F. Research ethics committees

Where applicable, research ethics committees should examine the scientific justification, participant protections, consent arrangements, and risks associated with genomic research.

G. Individuals and affected families

Individuals should have meaningful opportunities to understand applicable testing requirements, challenge unlawful processing, correct relevant errors, and seek legal remedies.

These responsibilities should be clearly allocated. An accountability framework is ineffective if every institution assumes that another institution is responsible for protecting genomic privacy.

11. Proposed judicial test for compulsory genome accountability

A court or reviewing authority could use the following questions to analyse a disputed compulsory genomic measure, while applying the actual legal test required by the relevant jurisdiction.

Step 1: Identify the legal authority.
Does a valid law authorise the collection, analysis, or retention of the genetic information?

Step 2: Identify the purpose.
Is the measure directed towards a legitimate and sufficiently specific objective?

Step 3: Assess necessity.
Is genomic testing genuinely required, or could the objective be achieved through a less intrusive alternative?

Step 4: Examine proportionality.
Is the extent of collection, analysis, retention, and disclosure justified by the objective?

Step 5: Evaluate scientific reliability.
Are the methods valid, and are the results being interpreted within their scientific limitations?

Step 6: Examine safeguards.
Are confidentiality, access restrictions, retention limits, and review mechanisms adequate?

Step 7: Examine equality and procedural fairness.
Does the programme discriminate arbitrarily, and can affected individuals challenge its decisions?

Step 8: Determine remedies and responsibility.
If a violation occurred, which institution is responsible, and what remedy is authorised by law?

This framework draws on the principles in Puttaswamy, the DNA-testing cases, and comparative human-rights jurisprudence. It should not be mistaken for a judicial test formally adopted under the name Compulsory Genome Accountability Doctrine.

12. Critical legal challenges

Several difficulties remain even where a genomic programme has a lawful purpose.

12.1 Genetic information concerns relatives as well as individuals

A person's genome may reveal information about biological relatives who have not consented to testing.

Consequently, an institution cannot always treat genomic information as concerning only the person who supplied the sample.

12.2 Anonymisation may not eliminate every risk

Genomic information can sometimes be linked with other datasets to infer identity or familial relationships. Removing names from a database is therefore not necessarily sufficient to eliminate every privacy risk.

12.3 Scientific interpretation changes over time

A sample collected for one purpose may support additional inferences as analytical methods improve.

This creates a governance problem: should an institution be permitted to perform new analyses simply because it already possesses the sample?

The proposed doctrine would require the institution to identify an appropriate legal basis for the new use rather than assuming that the original collection authorises every future analysis.

12.4 Consent may be compromised by unequal bargaining power

A person may technically agree to genetic testing but feel unable to refuse because employment, healthcare, education, or access to a public service depends on participation.

Governance should therefore consider whether consent is genuinely voluntary where consent is the relevant legal basis.

12.5 Accountability must include both public and private institutions

State agencies may exercise coercive powers, while private companies may control large genomic databases.

The legal duties applicable to these institutions may differ, but private possession of genomic information does not mean that privacy, confidentiality, contractual, or statutory obligations automatically disappear.

13. Conclusion

Compulsory Genome Accountability Doctrine and Governance is best understood as a proposed framework for ensuring that compulsory genetic testing and genomic-data processing remain lawful, necessary, proportionate, scientifically reliable, non-arbitrary, and subject to effective oversight.

The most important authorities include:

1. K.S. Puttaswamy v. Union of India (2017) — constitutional privacy and proportionality.
2. R. Rajendran v. Kamar Nisha (2025) — limits on compulsory DNA testing in parentage disputes.
3. Bhabani Prasad Jena v. Orissa State Commission for Women (2010) — judicial restraint in ordering DNA tests.
4. Selvi v. State of Karnataka (2010) — constitutional limits on compelled scientific investigative techniques.
5. S. and Marper v. United Kingdom (2008) — privacy and disproportionate retention of DNA information.
6. Maryland v. King (2013) — constitutionality of a particular statutory DNA-identification programme in the United States.

Taken together, these authorities demonstrate that scientific capability does not automatically establish legal authority. The ability to obtain genetic information does not, by itself, justify compelling a person to provide it, retaining it indefinitely, or using it for purposes unrelated to its lawful collection.

The central governance objective is therefore not to prohibit every form of compulsory genetic testing. It is to ensure that any such testing is authorised by law, justified by a legitimate purpose, limited to what is necessary, scientifically defensible, and accompanied by safeguards and remedies appropriate to the circumstances.

This is a general legal research explanation, not legal advice for a particular dispute. The precise outcome will depend on the applicable legislation, jurisdiction, and facts.